{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:27:09Z","timestamp":1789396029086,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,5,3]],"date-time":"2014-05-03T00:00:00Z","timestamp":1399075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11060-014-1450-1","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T09:25:18Z","timestamp":1399022718000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status"],"prefix":"10.1007","volume":"118","author":[{"given":"Aaron J.","family":"Lindsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Z.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,3]]},"reference":[{"issue":"6","key":"1450_CR1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3171\/jns.1993.79.6.0859","volume":"79","author":"DC Miller","year":"1993","unstructured":"Miller DC, Lang FF, Epstein FJ (1993) Central nervous system gangliogliomas. Part 1: pathology. J Neurosurg 79(6):859\u2013866. doi: 10.3171\/jns.1993.79.6.0859","journal-title":"J Neurosurg"},{"issue":"2","key":"1450_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109","journal-title":"Acta Neuropathol"},{"key":"1450_CR3","volume-title":"WHO classification of tumours of the central nervous system","year":"2007","unstructured":"Louis DN, Wiestler OD, Ohgaki H, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon"},{"issue":"2","key":"1450_CR4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11060-010-0248-z","volume":"101","author":"R DeMarchi","year":"2011","unstructured":"DeMarchi R, Abu-Abed S, Munoz D, Loch Macdonald R (2011) Malignant ganglioglioma: case report and review of literature. J Neurooncol 101(2):311\u2013318","journal-title":"J Neurooncol"},{"issue":"2","key":"1450_CR5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1019661528350","volume":"59","author":"S-H Im","year":"2002","unstructured":"Im S-H, Chung CK, Cho B-K, Wang K-C, Yu I-K, Song IC, Cheon GJ, Lee DS, Kim N-R, Chi JG (2002) Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol 59(2):173\u2013183","journal-title":"J Neurooncol"},{"issue":"1","key":"1450_CR6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncr.20332","volume":"101","author":"C Luyken","year":"2004","unstructured":"Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J (2004) Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8\u00a0years. Cancer 101(1):146\u2013155","journal-title":"Cancer"},{"issue":"5","key":"1450_CR7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006123-199805000-00049","volume":"42","author":"CS Rumana","year":"1998","unstructured":"Rumana CS, Valadka AB (1998) Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery 42(5):1038\u20131043","journal-title":"Neurosurgery"},{"issue":"1","key":"1450_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.crad.2007.06.010","volume":"63","author":"D Zhang","year":"2008","unstructured":"Zhang D, Henning TD, Zou LG, Hu LB, Wen L, Feng XY, Dai SH, Wang WX, Sun QR, Zhang ZG (2008) Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients. Clin Radiol 63(1):80\u201391. doi: 10.1016\/j.crad.2007.06.010","journal-title":"Clin Radiol"},{"key":"1450_CR9","doi-asserted-by":"crossref","unstructured":"Lagares A, Gomez PA, Lobato RD, Ricoy JR, Ramos A, de la Lama A (2001) Ganglioglioma of the brainstem: report of three cases and review of the literature. Surg Neurol 56(5):315\u2013322; discussion 314\u2013322","DOI":"10.1016\/S0090-3019(01)00618-8"},{"issue":"7","key":"1450_CR10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clineuro.2008.03.017","volume":"110","author":"YS Park","year":"2008","unstructured":"Park YS, Kim D-S, Shim K-W, Kim J-H, Choi J-U (2008) Factors contributing to resectability and seizure outcomes in 44 patients with ganglioglioma. Clin Neurol Neurosurg 110(7):667\u2013673","journal-title":"Clin Neurol Neurosurg"},{"issue":"4 Suppl","key":"1450_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3171\/ped.2007.107.4.286","volume":"107","author":"B Baussard","year":"2007","unstructured":"Baussard B, Di Rocco F, Garnett MR, Boddaert N, Lellouch-Tubiana A, Grill J, Puget S, Roujeau T, Zerah M, Sainte-Rose C (2007) Pediatric infratentorial gangliogliomas: a retrospective series. J Neurosurg 107(4 Suppl):286\u2013291","journal-title":"J Neurosurg"},{"issue":"6","key":"1450_CR12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3171\/jns.1993.79.6.0867","volume":"79","author":"FF Lang","year":"1993","unstructured":"Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR, Miller DC (1993) Central nervous system gangliogliomas. Part 2: clinical outcome. J Neurosurg 79(6):867\u2013873. doi: 10.3171\/jns.1993.79.6.0867","journal-title":"J Neurosurg"},{"issue":"12","key":"1450_CR13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/jnnp.57.12.1497","volume":"57","author":"J Zentner","year":"1994","unstructured":"Zentner J, Wolf HK, Ostertun B, Hufnagel A, Campos MG, Solymosi L, Schramm J (1994) Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry 57(12):1497\u20131502","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1450_CR14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/pbc.24232","volume":"59","author":"MH Chan","year":"2012","unstructured":"Chan MH, Kleinschmidt-Demasters BK, Donson AM, Birks DK, Foreman NK, Rush SZ (2012) Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry. Pediatr Blood Cancer 59(7):1173\u20131179","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1450_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3340\/jkns.2008.43.3.165","volume":"43","author":"S-H Park","year":"2008","unstructured":"Park S-H, Kim E, Son E-I (2008) Cerebellar ganglioglioma. J Korean Neurosurg Soc 43(3):165\u2013168","journal-title":"J Korean Neurosurg Soc"},{"issue":"7","key":"1450_CR16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.onc.1210704","volume":"27","author":"C Michaloglou","year":"2008","unstructured":"Michaloglou C, Vredeveld LCW, Mooi WJ, Peeper DS (2008) BRAF(E600) in benign and malignant human tumours. Oncogene 27(7):877\u2013895","journal-title":"Oncogene"},{"key":"1450_CR17","doi-asserted-by":"crossref","unstructured":"Sullivan RJ, Flaherty KT (2011) BRAF in melanoma: pathogenesis, diagnosis, inhibition, and resistance. J Skin Cancer 2011:423239","DOI":"10.1155\/2011\/423239"},{"issue":"6892","key":"1450_CR18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949\u2013954","journal-title":"Nature"},{"issue":"3","key":"1450_CR19","doi-asserted-by":"crossref","first-page":"e59221","DOI":"10.1371\/journal.pone.0059221","volume":"8","author":"A Skorokhod","year":"2013","unstructured":"Skorokhod A, Helmbold P, Brors B, Schirmacher P, Enk A, Penzel R (2013) Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600). PLoS ONE 8(3):e59221. doi: 10.1371\/journal.pone.0059221","journal-title":"PLoS ONE"},{"issue":"6","key":"1450_CR20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PTC Wan","year":"2004","unstructured":"Wan PTC, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R (2004) Mechanism of activation of the RAF\u2013ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116(6):855\u2013867","journal-title":"Cell"},{"issue":"5","key":"1450_CR21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bpa.12048","volume":"23","author":"C Chappe","year":"2013","unstructured":"Chappe C, Padovani L, Scavarda D, Forest F, Nanni-Metellus I, Loundou A, Mercurio S, Fina F, Lena G, Colin C, Figarella-Branger D (2013) Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol 23(5):574\u2013583. doi: 10.1111\/bpa.12048","journal-title":"Brain Pathol"},{"issue":"6","key":"1450_CR22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00401-013-1120-y","volume":"125","author":"S Dahiya","year":"2013","unstructured":"Dahiya S, Haydon DH, Alvarado D, Gurnett CA, Gutmann DH, Leonard JR (2013) BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma. Acta Neuropathol 125(6):901\u2013910. doi: 10.1007\/s00401-013-1120-y","journal-title":"Acta Neuropathol"},{"key":"1450_CR23","doi-asserted-by":"crossref","unstructured":"Donson AM, Kleinschmidt-Demasters BK, Aisner DL, Bemis LT, Birks DK, Levy JM, Smith AA, Handler MH, Foreman NK, Rush SZ Pediatric brainstem gangliogliomas show BRAF mutation in a high percentage of cases. Brain Pathol. doi: 10.1111\/bpa.12103","DOI":"10.1111\/bpa.12103"},{"issue":"7","key":"1450_CR24","first-page":"621","volume":"12","author":"MJ Dougherty","year":"2010","unstructured":"Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, Storm PB, Biegel JA (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neurooncology 12(7):621\u2013630","journal-title":"Neurooncology"},{"key":"1450_CR25","doi-asserted-by":"crossref","unstructured":"Koelsche C, Wohrer A, Jeibmann A, Schittenhelm J, Schindler G, Preusser M, Lasitschka F, von Deimling A, Capper D Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol 125(6):891\u2013900. doi: 10.1007\/s00401-013-1100-2","DOI":"10.1007\/s00401-013-1100-2"},{"issue":"11","key":"1450_CR26","doi-asserted-by":"crossref","first-page":"e7887","DOI":"10.1371\/journal.pone.0007887","volume":"4","author":"LE MacConaill","year":"2009","unstructured":"MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA (2009) Profiling critical cancer gene mutations in clinical tumor samples. PLoS ONE 4(11):e7887. doi: 10.1371\/journal.pone.0007887","journal-title":"PLoS ONE"},{"issue":"6","key":"1450_CR27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1593\/tlo.12328","volume":"5","author":"JK Myung","year":"2012","unstructured":"Myung JK, Cho H, Park CK, Kim SK, Lee SH, Park SH (2012) Analysis of the BRAF(V600E) mutation in central nervous system tumors. Transl Oncol 5(6):430\u2013436","journal-title":"Transl Oncol"},{"issue":"3","key":"1450_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121(3):397\u2013405","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1450_CR29","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1200\/JCO.2012.44.1568","volume":"31","author":"S Rush","year":"2013","unstructured":"Rush S, Foreman N, Liu A (2013) Brainstem ganglioglioma successfully treated with vemurafenib. J Clin Oncol 31(10):e159\u2013e160. doi: 10.1200\/JCO.2012.44.1568","journal-title":"J Clin Oncol"},{"issue":"4","key":"1450_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000121252","volume":"27","author":"JH Johnson","year":"1997","unstructured":"Johnson JH, Hariharan S, Berman J, Sutton LN, Rorke LB, Molloy P, Phillips PC (1997) Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20\u00a0years. Pediatr Neurosurg 27(4):203\u2013207","journal-title":"Pediatr Neurosurg"},{"issue":"2","key":"1450_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.sult.2013.01.001","volume":"34","author":"A Ramos","year":"2013","unstructured":"Ramos A, Hilario A, Lagares A, Salvador E, Perez-Nunez A, Sepulveda J (2013) Brainstem gliomas. Semin Ultrasound CT MRI 34(2):104\u2013112. doi: 10.1053\/j.sult.2013.01.001","journal-title":"Semin Ultrasound CT MRI"},{"issue":"24","key":"1450_CR32","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"JL Maldonado","year":"2003","unstructured":"Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95(24):1878\u20131890","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1450_CR33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00268-011-1383-1","volume":"36","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo do H, Youn YK (2012) BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg 36(2):310\u2013317. doi: 10.1007\/s00268-011-1383-1","journal-title":"World J Surg"},{"issue":"7","key":"1450_CR34","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.26500","volume":"118","author":"TH Kim","year":"2012","unstructured":"Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH, Cho BY, Park do J (2012) The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer 118(7):1764\u20131773. doi: 10.1002\/cncr.26500","journal-title":"Cancer"},{"issue":"5","key":"1450_CR35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","volume":"91","author":"RP Tufano","year":"2012","unstructured":"Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M (2012) BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine (Baltim) 91(5):274\u2013286. doi: 10.1097\/MD.0b013e31826a9c71","journal-title":"Medicine (Baltim)"},{"issue":"24","key":"1450_CR36","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1158\/1078-0432.CCR-11-1456","volume":"17","author":"TP Nicolaides","year":"2011","unstructured":"Nicolaides TP, Li H, Solomon DA, Hariono S, Hashizume R, Barkovich K, Baker SJ, Paugh BS, Jones C, Forshew T, Hindley GF, Hodgson JG, Kim JS, Rowitch DH, Weiss WA, Waldman TA, James CD (2011) Targeted therapy for BRAFV600E malignant astrocytoma. Clin Cancer Res 17(24):7595\u20137604. doi: 10.1158\/1078-0432.CCR-11-1456","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1450_CR37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/0008-5472.CAN-09-1851","volume":"70","author":"JD Schiffman","year":"2010","unstructured":"Schiffman JD, Hodgson JG, VandenBerg SR, Flaherty P, Polley M-YC, Yu M, Fisher PG, Rowitch DH, Ford JM, Berger MS, Ji H, Gutmann DH, James CD (2010) Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res 70(2):512\u2013519","journal-title":"Cancer Res"},{"issue":"10","key":"1450_CR38","doi-asserted-by":"crossref","first-page":"e47054","DOI":"10.1371\/journal.pone.0047054","volume":"7","author":"G Safaee Ardekani","year":"2012","unstructured":"Safaee Ardekani G, Jafarnejad SM, Tan L, Saeedi A, Li G (2012) The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis. PLoS ONE 7(10):e47054. doi: 10.1371\/journal.pone.0047054","journal-title":"PLoS ONE"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1450-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-014-1450-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1450-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:17:50Z","timestamp":1559348270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-014-1450-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s11060-014-1450-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,3]]}}}